SCA
INSM icon

Snowden Capital Advisors’s Insmed INSM Stock Holding History

Snowden Capital Advisors’s Portfolio INSM Stock Details INSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.24M Buy
7,571
+337
+5% +$51.8K 0.03% 468
2025
Q4 		$1.26M Sell
7,234
-535
-7% -$97.6K 0.03% 452
2025
Q3 		$1.12M Buy
7,769
+46
+0.6% +$5.63K 0.03% 493
2025
Q2 		$777K Buy
7,723
+1,483
+24% +$113K 0.02% 598
2025
Q1 		$476K Sell
6,240
-362
-5% -$27.7K 0.02% 765
2024
Q4 		$456K Buy
6,602
+158
+2% +$11.4K 0.01% 808
2024
Q3 		$470K Buy
6,444
+416
+7% +$30.7K 0.01% 799
2024
Q2 		$404K Buy
+6,028
New +$234K 0.01% 850

Other funds holding INSM

JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.77B AUM 307.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Snowden Capital Advisors's INSM Position: Q1 2026 in Review

Snowden Capital Advisors increased its Insmed (INSM) stake by 4.7% in Q1 2026, buying an estimated $51.8K and bringing the position to 7,571 shares worth $1.24M. The position accounts for 0.03% of the portfolio, ranked #468.

Snowden Capital Advisors first reported a position in INSM in Q2 2024 and has held it in 8 quarters since. The position peaked at $1.26M in Q4 2025. 669 funds tracked by Wall St. Rank hold INSM as of Q1 2026.

  • Snowden Capital Advisors held 7,571 shares of Insmed worth $1.24M as of Q1 2026.
  • Snowden Capital Advisors bought 337 Insmed shares in Q1 2026, an estimated $51.8K.
  • Insmed made up 0.03% of Snowden Capital Advisors's portfolio in Q1 2026, its #468 holding.
  • Snowden Capital Advisors first reported a position in Insmed in Q2 2024 and has held it in 8 quarters since.
  • Snowden Capital Advisors's Insmed position peaked at $1.26M in Q4 2025.
  • 669 funds tracked by Wall St. Rank held Insmed as of Q1 2026.

Based on Snowden Capital Advisors's 13F filing for Q1 2026, filed 15 May 2026.